Key Documents
Darrell Wilson
Academic Appointments
- Professor - Med Center Line, Pediatrics - Endocrinology
- Member, Bio-X
Contact Information
-
Clinical Offices
Medicine Specialties Clinic 730 Welch Rd 2nd Floor Palo Alto, CA 94304 Tel Work (650) 736-7642 Fax (650) 725-8375Practices at Stanford Hospital and Clinics and Lucile Packard Children's Hospital
- Academic Offices
Personal Information Email Tel (650) 723-5791Not for medical emergencies or patient use
Professional Snapshot
Clinical Focus
- Endocrinology/Diabetes, Pediatric
- Pediatric Endocrinology
Professional Education
| Board Certification: | Pediatric Endocrinology, American Board of Pediatrics (1995) |
| Fellowship: | SUMC - Graduate Medical Education, CA (1984) |
| Board Certification: | General Pediatrics, American Board of Pediatrics (1982) |
| Residency: | SUMC - Graduate Medical Education, CA (1980) |
| Internship: | Stanford University School of Medicine, CA (1978) |
Postdoctoral Advisees
Web Site Links
Industry Relationships
Stanford is committed to ethical and transparent interactions with our industry partners. It is our policy to disclose payments of $5,000 or more, equity valued at $5,000 or more in a publicly traded company, or any equity in a privately held company, to physicians and scientists employed by Stanford University from companies or other commercial entities with which they interact as part of their professional activities. View Full Information
| Consulting: | Various Legal Cases |
Scientific Focus
Current Research Interests
My research interests cover a number of areas in Pediatric Endocrinology and Diabetes. I am PI of the Stanford Center for the NIH-funded Type-1 Diabetes TrialNet group. TrialNet conducts clinical trials directed at preventing or delaying the onset of Type 1 diabetes. I am an investigator in DirecNet, another NIH-funded study group, which is devoted to evaluating glucose sensors and the role of technology on the management of diabetes.
Clinical Trials
- Oral Insulin for Prevention of Diabetes in Relatives at Risk for Type 1 Diabetes Mellitus Recruiting
- Comparison of transdermal and oral estrogens in adolescent girls with ovarian failure Recruiting
- Effects of Rituximab on the Progression of Type 1 Diabetes in New Onset Subjects No longer recruiting
- T Cell Validation Study Using Blood Samples From Subjects With Recent Onset Type 1 Diabetes Mellitus Completed
- Pilot Study to Evaluate a Method of Controlling High Blood Sugar in the Pediatric Intensive Care Unit Completed
Publications
- Failure to Preserve beta-cell function with Mycophenolate Mofetil and Daclizumab Combined Therapy in patients with new onset Type 1 Diabetes. Diabetes Care. 2010
- Rituximab, B-lymphocyte depletion, and preservation of beta-cell function. N Engl J Med. 2009; (22): 2143-52
- Duration of nocturnal hypoglycemia before seizures. Diabetes Care. 2008; (11): 2110-2
- Low-fat vs. high-fat bedtime snacks in children and adolescents with type 1 diabetes. Pediatr Diabetes. 2008; (4 Pt 1): 320-5
- Stanford GEMS phase 2 obesity prevention trial for low-income African-American girls: design and sample baseline characteristics. Contemp Clin Trials. 2008; (1): 56-69
Help